Annual EBITDA
-$1.26B$158.51M-14.33%
Summary
- Current Value
- As of today, ROIV annual EBITDA is -$1.26B, down -14.33% on
- Historical Performance
- ROIV annual EBITDA is down -20.33% over the past 3 years, down -41.21% over the past 5 years
- All-Time High Comparison
- ROIV annual EBITDA is currently -55.32% below its historical high of -$814.35M set on
- 3-Year Low Comparison
- ROIV annual EBITDA is at its 3-year low
- Sector Comparison
- ROIV annual EBITDA is higher than 0.26% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$1.26B | -14.3% | -20.3% | -41.2% | – | |
| Quarterly EBITDA | -$365.79M | -28.9% | -42.6% | -136.9% | – | |
| TTM EBITDA | -$1.36B | -15.3% | -32.1% | -162.3% | – | |
| Price | $36.20 | +208.1% | +209.1% | +264.6% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $8.26M | -71.6% | -86.5% | -65.3% | +255.4% | |
| Annual EPS | -$0.43 | -82.2% | +69.5% | +88.1% | +91.1% | |
| -$1.27B | -13.9% | -17.7% | -18.4% | -69.4% | ||
| Annual Net Income | -$397.91M | +45.5% | +67.7% | +55.8% | +50.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$814.35M | -55.3% | |
| 5Y | -$814.35M | -55.3% | |
| All | -$814.35M | -55.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$1.26B | at low | |
| 5Y | -$1.26B | at low | |
| All | -$1.26B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$1.26B | -14.3% | |
| -$1.11B | -35.9% | |
| -$814.35M | +22.5% |
| Year | Value | Change |
|---|---|---|
| -$1.05B | -15.4% | |
| -$910.77M | -1.7% | |
| -$895.74M | - |
FAQ
- What is the current annual EBITDA of ROIV?
- As of today, ROIV annual EBITDA is -$1.26B
- What is 1-year change in ROIV annual EBITDA?
- ROIV annual EBITDA is down -14.33% year-over-year
- What is 3-year change in ROIV annual EBITDA?
- ROIV annual EBITDA is down -20.33% over the past 3 years
- How far is ROIV annual EBITDA from its all-time high?
- ROIV annual EBITDA is currently -55.32% below its historical high of -$814.35M set on March 31, 2024
- How does ROIV annual EBITDA rank versus sector peers?
- ROIV annual EBITDA is higher than 0.26% of companies in Healthcare sector
- When is ROIV next annual earnings release?
- As of today, the next annual earnings release for ROIV has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$365.79M$11.43M-3.22%
Summary
- Current Value
- As of today, ROIV quarterly EBITDA is -$365.79M, down -3.22% on
- Historical Performance
- ROIV quarterly EBITDA is down -28.88% year-over-year, down -42.63% over the past 3 years
- All-Time High Comparison
- ROIV quarterly EBITDA is currently -192.15% below its historical high of -$125.20M set on
- 3-Year Low Comparison
- ROIV quarterly EBITDA is at its 3-year low
- Sector Comparison
- ROIV quarterly EBITDA is higher than 0.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$365.79M | -3.2% | -28.9% | -42.6% | -136.9% | |
| Annual EBITDA | -$1.26B | – | -14.3% | -20.3% | -41.2% | |
| TTM EBITDA | -$1.36B | -6.4% | -15.3% | -32.1% | -162.3% | |
| Price | $36.20 | +22.7% | +208.1% | +209.1% | +264.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.44M | -42.8% | -33.5% | -93.3% | -81.4% | |
| Quarterly EPS | -$0.26 | -170.6% | +19.8% | +31.5% | +28.8% | |
| -$366.39M | -3.2% | -28.6% | -38.8% | -137.3% | ||
| Quarterly Net Income | -$290.61M | -181.7% | -6.1% | +11.4% | -187.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$283.82M | N/A | -28.9% |
| 3Y | -$201.68M | -81.4% | |
| 5Y | -$125.20M | -192.2% | |
| All | -$125.20M | -192.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$365.79M | at low | |
| 3Y | -$365.79M | at low | |
| 5Y | -$684.43M | +46.6% | |
| All | -$684.43M | +46.6% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ROIV?
- As of today, ROIV quarterly EBITDA is -$365.79M
- What is ROIV quarterly EBITDA most recent change?
- ROIV quarterly EBITDA was down -3.22% on June 30, 2026
- What is 1-year change in ROIV quarterly EBITDA?
- ROIV quarterly EBITDA is down -28.88% year-over-year
- How far is ROIV quarterly EBITDA from its all-time high?
- ROIV quarterly EBITDA is currently -192.15% below its historical high of -$125.20M set on March 31, 2022
- How does ROIV quarterly EBITDA rank versus sector peers?
- ROIV quarterly EBITDA is higher than 0.38% of companies in Healthcare sector
- When is ROIV next earnings release?
- The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$1.36B$81.96M-6.39%
Summary
- Current Value
- As of today, ROIV TTM EBITDA is -$1.36B, down -6.39% on
- Historical Performance
- ROIV TTM EBITDA is down -15.34% year-over-year, down -32.14% over the past 3 years
- All-Time High Comparison
- ROIV TTM EBITDA is currently -272.99% below its historical high of -$365.67M set on
- 3-Year Low Comparison
- ROIV TTM EBITDA is at its 3-year low
- Sector Comparison
- ROIV TTM EBITDA is higher than 0.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$1.36B | -6.4% | -15.3% | -32.1% | -162.3% | |
| Annual EBITDA | -$1.26B | – | -14.3% | -20.3% | -41.2% | |
| Quarterly EBITDA | -$365.79M | -3.2% | -28.9% | -42.6% | -136.9% | |
| Price | $36.20 | +22.7% | +208.1% | +209.1% | +264.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $7.53M | -8.8% | -67.6% | -90.4% | -67.1% | |
| TTM EPS | -$0.44 | +12.9% | +37.2% | +67.3% | +83.5% | |
| -$1.37B | -6.3% | -15.2% | -29.0% | -96.6% | ||
| TTM Net Income | -$414.60M | -4.2% | +57.4% | +65.6% | +37.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.15B | -19.1% | |
| 3Y | -$832.64M | -63.8% | |
| 5Y | -$520.06M | N/A | -162.3% |
| All | -$365.67M | -273.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.36B | at low | |
| 3Y | -$1.36B | at low | |
| 5Y | -$1.45B | +5.9% | |
| All | -$1.45B | +5.9% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ROIV?
- As of today, ROIV TTM EBITDA is -$1.36B
- What is ROIV TTM EBITDA most recent change?
- ROIV TTM EBITDA was down -6.39% on June 30, 2026
- What is 1-year change in ROIV TTM EBITDA?
- ROIV TTM EBITDA is down -15.34% year-over-year
- How far is ROIV TTM EBITDA from its all-time high?
- ROIV TTM EBITDA is currently -272.99% below its historical high of -$365.67M set on March 31, 2021
- How does ROIV TTM EBITDA rank versus sector peers?
- ROIV TTM EBITDA is higher than 0.38% of companies in Healthcare sector
- When is ROIV next earnings release?
- The next earnings release for ROIV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ROIV Official Website roivant.com
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv